Overview
This article presents AVMCH's structured perspective on emerging biomarkers for early detection of acute myocardial infarction, consolidating current evidence, practical protocols, and implementation insights for academic and clinical teams.
Conclusion
The findings reinforce AVMCH's commitment to evidence-based medical practice and continuous quality advancement in patient care and education.